Forbes -
17 Jan 2013 23:53
Medtronic (MDT) was upgraded by Credit Suisse (CS) to outperform from neutral as the firm believes that growth at the company should exceed that of consensus estimates during the next few quarters.
Share this Article
Comment on this Article
Please to comment